Sartorius Stedim Biotech S.A.
$20.90▲ 2.20%(+$0.45)
TickerSpark Score
52/100
▌ Mixed
47
Valuation
65
Profitability
25
Growth
72
Health
50
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRTOY research report →
52-Week Range39% of range
Low
$17.25
Current
$20.90
High
$26.54
Company Overviewwww.sartorius.com
About the company
Sartorius Stedim Biotech S. A. operates globally, providing essential instruments and consumables to the biopharmaceutical industry.
- CEO
- Rene Faber
- IPO
- 2022
- Employees
- 9,961
- HQ
- Aubagne, FR
Price Chart
-13.56% · this period
Valuation
- Market Cap
- $203.34B
- P/E
- 65.53
- P/S
- 5.87
- P/B
- 4.27
- EV/EBITDA
- 23.29
- Div Yield
- 0.38%
Profitability
- Gross Margin
- 44.71%
- Op Margin
- 18.47%
- Net Margin
- 8.98%
- ROE
- 6.60%
- ROIC
- 5.47%
Growth & Income
- Revenue
- $2.85B · 2.53%
- Net Income
- $255.12M · 45.70%
- EPS
- $0.03 · -85.64%
- Op Income
- $527.33M
- FCF YoY
- -70.62%
Performance & Tape
- 52W High
- $26.54
- 52W Low
- $17.25
- 50D MA
- $19.65
- 200D MA
- $21.84
- Beta
- 1.15
- Avg Volume
- 40.59K
Get TickerSpark's AI analysis on SRTOY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · SRTOY
Our SRTOY coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on SRTOY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SRTOY report →Internal Compare
Similar companies
Peers in the same neighborhood.